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Protein-protein transient and dynamic interactions underlie all biological processes. The molecular dynamics
(MD) of the E9 colicin DNase protein, its Im9 inhibitor protein, and their E9-Im9 recognition complex are
investigated by combining multiple-copy (MC) MD and accelerated MD (aMD) explicit-solvent simulation
approaches, after validation with crystalline-phase and solution experiments. Im9 shows higher ﬂexibility
than its E9 counterpart. Im9 displays a signiﬁcant reduction of backbone ﬂexibility and a remarkable increase
in motional correlation upon E9 association. Im9 loops 23-31 and 54-64 open with respect to the E9-Im9
X-ray structure and show high conformational diversity. Upon association a large fraction (∼20 nm2)o fE 9
and Im9 protein surfaces become inaccessible to water. Numerous salt bridges transiently occurring throughout
our six 50 ns long MC-MD simulations are not present in the X-ray model. Among these Im9 Glu31-E9
Arg96 and Im9 Glu41-Lys89 involve interface interactions. Through the use of 10 ns of Im9 aMD simulation,
we reconcile the largest thermodynamic impact measured for Asp51Ala mutation with Im9 structure and
dynamics. Lys57 acts as an essential molecular switch to shift Im9 surface loop towards an ideal conﬁguration
for E9 inhibition. This is achieved by switching Asp60-Lys57 and Asp62-Lys57 hydrogen bonds to
Asp51-Lys57 salt bridge. E9-Im9 recognition involves shifts of conformational distributions, reorganization
of intramolecular hydrogen bond patterns, and formation of new inter- and intramolecular interactions. The
description of key transient biological interactions can be signiﬁcantly enriched by the dynamic and atomic-
level information provided by computer simulations.
Introduction
Many proteins form complexes with one or more binding
partner(s) to fulﬁll their highly speciﬁc, yet multiple tasks in
living organisms. This yields a signiﬁcantly higher number of
protein-protein complexes than proteins in the proteome.
Aberrant association generally results in disease.1,2 Conse-
quently, understanding protein-protein association at the mo-
lecular level,3-8 discriminating between highly-speciﬁc asso-
ciation and nonspeciﬁc aggregation processes,9-12 designing
drugs capable of inhibiting biomolecular association,4-6,9,13-15
and developing computational approaches to predict favorable
binding partners, dominant physicochemical interactions, and
aggregation-prone segments16-19 are all targets of intense
research. Here we focus on transient protein complexes, those
whose unbound partners are stable in solution.
The study of protein-protein interactions (PPI) is several
decades old; see for example the early pioneering work by
Chothia and Janin.20 Since than much has been learned about
PPIs. For example, the fraction of nonpolar surface area at
complex interfaces is nearly the same as in the surface of
globular proteins.21 Furthermore, solute-solute electrostatic
interactions are not always exclusively favorable for binding
and their contribution seems highly system dependent.10 Thus,
in a number of cases hydrophobic effects and a thermodynami-
cally favorable solvent-solvent and solute-solvent re-organization
seem to dominate the binding process.10,22,23 Some evidence
suggests that burying backbone amide hydrogen bonds is a
signiﬁcant driving factor in PPIs.23 However, other studies
propose individual interface side-chains as binding determi-
nants.24 On the basis of Ala scanning experiments, only a few
(hot spot) residues at the interface of the human growth-hormone
and its receptor make a signiﬁcant contribution to binding.
Further studies reported similar results in the context of other
systems.25-27 Screening of a database combining structural and
thermochemical data of Ala mutants suggested that protein
interfaces involve a central hydrophobic region surrounded by
polar/charged residues that exclude the solvent from the
hydrophobic center, that is, the “O-ring” hypothesis.28
Our current knowledge of protein-protein association is
largelybasedonstructuresinferredbyX-raycrystallography8,20,21,29
and nuclear magnetic resonance (NMR) in solution.30-36 This
structural information can be linked to thermodynamic quantities
calculated on the basis of association/dissociation kinetics
experiments.29,31,37,38
However, elucidating the relationship between protein
dynamics and thermodynamic properties at the molecular
level is currently hampered by three major limitations. First,
the physico-chemical environment experienced during struc-
tural determination (i.e., generally the crystalline phase at
low temperature) is typically different from the environment
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generally a solution of protein complexes at room temper-
ature). Second, the interpretation of these (bio)physical
experiments is often nontrivial even when including dynami-
cal information due to space/time ensemble-averaging effects
(ref 39 and refs therein; refs 40-43). Third, adding to the
complexity of performing these experiments, a signiﬁcant
fraction of protein-protein complexes occurring in nature
is difﬁcult to study through classical experiments due to
sample aggregation. For example, these three limitations may
lead to signiﬁcantly different interpretations of the changes
of ﬂexibility and hydration upon protein-protein association.
Additionally, due to ﬁnite crystallographic resolution and
reﬁnement modeling accuracy, they may limit the description
of molecular interactions (e.g., salt bridges and hydrogen
bonds) essential for biomolecular recognition.
Molecular dynamics (MD) simulation with empirical force
ﬁelds is a useful theoretical tool to study the properties of
(bio)molecular systems with atomic resolution based on classical
mechanics.43-45 They complement experimental results by
providing distributions and time series of, in principle, any
physically deﬁnable observable, within force ﬁeld accuracy and
ﬁnite sampling limitations. When combined with an explicit
treatment of solvent molecules, MD simulations capture changes
of structure, dynamics, interactions, and thermodynamics of
biomolecular association.16,46-50
The separate sampling of the bound and unbound states is
the key to describe conformational dynamics differences upon
association. While this is possible in silico, it may be impossible
in vitro, because associating partners in protein-protein com-
plexes may be insufﬁciently stable or difﬁcult to purify in
solution when individually unbound. For example, MD simula-
tions can be used to study aspects of protein-protein association,
like the conformational-selection hypothesis51 and the pre-
organization52 of key residues, based on the independent bound
and unbound ensembles of trajectory structures. However, the
application of accurate computational chemistry technologies
to protein-protein association remains non-standard due to their
relatively high computational cost. Here, we overcome this
general limitation by means of an integrated multiple-copy (MC;
e.g. refs 44, 53, 54) MD and accelerated MD (aMD; refs 55,
56) simulation approach.
The structure and dynamics of the of E9 colicin DNase
(deoxyribonuclease) in complex with its Im9 inhibitor protein
has been extensively studied via solution NMR30-32,57-59 and
kinetic experiments.29,31,37 A structural ensemble has been
reported for Im9 based on NMR experiments.57 X-ray crystal-
lographic structures of the E9-Im9 complex8 and of the E9
unbound protein (PDB ID: 1fsj) have also been reported.
The major interest in E9-Im9 association dynamics derives
from its biological role. E. coli under stress conditions secrete
colicin DNases (E9) to destroy the DNA of competing bacteria.7
In order to protect themselves from the DNase activity, they
also produce the Im9 immunity protein that inhibits the colicin
DNase. Each DNase in this protein family speciﬁcally binds
an immunity protein (∼42 kJ mol-1 partner preference; ∼84
kJ mol-1 overall binding free energy).7,60 However, biomolecular
association with non-cognate partners can still be signiﬁcantly
favorable.60 Previous studies suggested that the E9-Im9 interface
has two hot-spot regions, which would permit cross talk and
high speciﬁcity among other members of the colicin DNase
family.29
The thermodynamic impact on Im9 protein stability and E9-
binding has also been investigated based on association/
dissociation kinetics experiments.31 Binding seems mainly
perturbed by Asp51Ala (∼25 kJ mol-1) and Tyr54Ala and
Tyr55Ala (∼20 and ∼19 kJ mol-1) mutations. In the second
case, a direct structure/thermodynamics relationship was pro-
posed using the E9-Im9 X-ray structural model.8 However, no
clear understanding of the reasons for such a large effect on
binding after Asp51Ala mutation has been reported in the
literature.
In this work, we address this point using the detailed dynamic
picture of conformational sampling and molecular interaction
changes for the E9-Im9 interface upon complexation. We
investigate E9 and Im9 dynamics and their changes upon E9-
Im9 colicin DNase association based on a set of six 50 ns long
MC-MD simulations in explicit solvent (Table 1). In order to
(i) alleviate ﬁnite sampling effects, (ii) enhance the conforma-
tional sampling statistics, and (iii) assess the convergence of
MD simulations of protein systems in general, we employ two
independent MD runs, labeled a and b, for each of the key
thermodynamic states: unbound E9, unbound Im9, and E9-Im9
recognition complex.
We show that MC-MD allows more accurate monitoring of
both global (e.g. protein surface loop motion and backbone
motional correlation) and local (e.g., hydrogen-bonding and
dihedral) conformational dynamics, by increasing rare events
statistics. Additionally, in the case of the more ﬂexible Im9
protein, we use the aMD simulation technique55,56 to improve
sampling and capture slow protein motion and rare conforma-
tional changes. This technique allows us to solve the apparent
discrepancies between independent MC-MD trajectories for Im9
protein dynamics. Additionally, we demonstrate how good
sampling convergence from independent MC-MD runs can still
cover only a limited portion of the conformational space
accessible to a solvated protein system at thermodynamic
equilibrium, which can instead be visited extensively by aMD
simulation.
We focus the analysis of E9-Im9 colicin DNase complexation
and dynamics in water on a number of key points of biological
and biophysical relevance, after validating our simulations using
X-ray crystallography and solution NMR experimental data. We
describe the overall ﬂexibility, dynamics, motional correlation,
and solvent accessibility changes upon E9-Im9 binding. We
investigate 23-31 and 54-64 Im9 loops conformational
sampling, involved in the recognition process and in Im9 binding
speciﬁcity. We provide a time-dependent analysis of salt-bridge
formationandpre-organizationandinvestigateIm9Asp60-Lys57,
Asp62-Lys57, and Asp51-Lys57 interactions and their role
in E9-Im9 recognition through a surface-loop switch. This
analysis allows us to capture the link between protein dynamics
in solution and thermodynamic data based on kinetics experi-
ments. We characterize the changes of conformational sampling
and solute-solute hydrogen bonding of key E9-Im9 interface
residues. These ﬁndings are discussed in the general context of
protein-protein association, protein dynamics, and experiment
interpretation.
Methods
Molecular Model and Multiple-Copy Molecular Dynam-
ics. Initial coordinates (PDB ID: 1bxi) for the E9-Im9 complex8
including 104 crystallographic water molecules were used after
removing Ni+ and PO4
2- ions. The same coordinates for the
individual monomers (excluding water oxygens) were used to
initialize E9 and Im9 simulations (see Table 1 for reference
codes).
System topologies and coordinate ﬁles were generated with
the Amber 9 software.61 The parm99SB parameter set was
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Im9 systems were solvated in pre-equilibrated rectangular boxes
of Amber-compatible TIP3P water,64 large enough to avoid any
interaction between images under periodic boundary conditions.
Water molecules not corresponding to X-ray model water sites
were deleted if overlapping to any solute atom based on van
der Waals radii. Na+ and Cl- ions were added at random
positions to neutralize the overall system charge (Table 1) and
treated with parameters derived for the SPC water65 and adapted
for the TIP3P water model.61
For each system, successive energy minimization, heat-up,
and equilibration were performed employing different atom-
positional harmonic restraining potentials. During the ﬁrst stage
all protein atoms were restrained to their crystallographic
coordinates with a force constant of 209 kJ mol-1 nm-2 (0.5
kcal mol-1 Å-2) to relax the solvent. The second stage involved
the same potential applied on CR atoms only. The third stage
did not involve any restraint in order to remove any residual
strain. The heat-up procedure followed a similar scheme. In the
ﬁrst stage (50 ps) all atoms were restrained to their X-ray
coordinates (force constant as above), the temperature was
linearly increased, from 0.1 to 300 K, over the ﬁrst 30 ps. A
weak-coupling algorithm66 was employed using a single thermal
bath to the overall system (0.1 ps relaxation time). During
equilibration and production stages electrostatic interactions were
evaluatedusingtheParticleMeshEwald(PME)approximation67-69
under periodic boundary conditions (Ewald cutoff for direct
space sum of 0.8 nm). Independent copies for MC-MD
simulation were initialized using identical set-up, but different
initial velocities randomly assigned from Maxwell-Boltzmann
distributions at 50 K. At each 1 fs long MD integration step
the bonds to hydrogen atoms were kept ﬁxed using the SHAKE
algorithm.70 The second 50 ps stage involved a (NVT) simula-
tion at 300 K using a weaker restraining potential on all atoms
(force constant of 104 kJ mol-1 nm-2; 0.25 kcal mol-1 Å-2).
The third 100 ps stage with no restraint was performed by
coupling the system to a 1 bar pressure bath66 via isotropic
coordinate scaling (relaxation time 0.5 ps; isothermal compress-
ibility 4.6 10-4 [kJ mol-1 nm-3]-1). A general approach for
enhancing phase-space sampling in computer simulation is the
use of simultaneous or parallel MD simulations. Multiple-copy
approaches allows to speed-up phase-space sampling while
splitting the calculation into a number of independent runs.44,53,54
This is particularly appealing considering the rapid and steady
increase of computational power in the form of multiple CPU
clusters vs. single CPU supercomputers. In this study two
independent MC-MD runs at 300 K were extended for 50 ns
with the set up of stage three, as summarized in Table 1.
Accelerated Molecular Dynamics. Current MD simulations
cover timescales often too shorts to capture biological processes
dominated by rare events.43,44 In addition, regular atomistic MD
simulations of biomolecules may spend most of the simulation
time trapped in one or another local minimum.71,72 Therefore,
a number of alternative techniques have been developed to
enhance sampling.55,71-75
We employed the accelerated MD approach (aMD) that
deforms the energy landscape by adding a boost potential, ∆V(r),
to the original potential surface every time V(r) is below a pre-
deﬁned energy level E,a s 55
TABLE 1: Simulated Systems
a From X-ray crystal structure as in ref 8. b After energy minimization to relax the solvent molecules around the protein.
∆V(r) ) {
0, V(r) g E
(E - V(r))
2
R+(E - V(r))
, V(r) < E
(1)
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basins in the modiﬁed potential. In principle, this approach also
allows the correct quasi-canonical averages of an observable,
calculated from conﬁgurations sampled on the modiﬁed potential
energy surface, to be recovered from aMD simulations.55 In
order to simultaneously enhance the sampling of internal and
diffusive degrees of freedom, a dual boosting approach was
employed.76 In this case, separate torsional and total boost
potentials are deﬁned as
where Vt(r) is the total potential of the torsional terms; ∆Vt(r)
and ∆VT(r) are the boost potentials applied respectively to the
torsional terms Vt(r) and the total potential energy VT(r), and
both follow the same deﬁnition as in eq 1 in combination with
Rt and RT parameters. The parameters of eqs 2 and 3 were set
as follows. Et ) 1168 kcal mol-1, that is, ∼300 kcal mol-1
higher than the ensemble-averaged torsional potential energy
from simulation Im9_b. Rt ≈ 60 kcal mol-1.77 ET ) 0.1 kcal
mol-1 (nr. atoms)-1 plus the ensemble-averaged total potential
energy from Im9_b. RT ≈ 0.1 kcal mol-1 (nr. atoms)-1.78 These
ET and RT values allow one to reproduce the most relevant
structural and energetic properties of liquid water while increas-
ing the water self-diffusion coefﬁcient by ∼15%.76,79 The quasi-
canonical re-weighting procedure to recover thermodynamically
meaningful ensemble conﬁgurations is described in ref 76.
Snapshots were extracted every 1 ps along the 10-ns Im9_aMD
trajectory for analysis.
Analysis Procedure. Trajectory snapshots were extracted
every 5 ps along each of the six equilibrated 50 ns MC-MD
trajectories E9_a, E9_b, Im9_a, Im9_b, E9-Im9_a, E9-Im9_b
for analysis.
Structural Fitting. Structural ﬁtting was performed by (i)
superimposing their centers of mass (to remove overall transla-
tion) and (ii) performing an atom-positional least-square ﬁtting
procedure (to remove overall rotation)80 using all CR atoms,
except those belonging to the ﬁrst and last ﬁve residues, unless
otherwise speciﬁed.
Secondary-Structure Monitoring. Secondary structure ele-
ments formation was monitored according to the deﬁnition by
Kabsch and Sander.81
Chemical-Shift Calculation. Im9 CR chemical shifts (δ) were
calculated using the SHIFTX program82 on individual structures
of each of the separate six MC-MD ensembles, using either all
50 ns equilibrium trajectories (104 snapshots) or only their ﬁnal
10 ns periods (2 × 103 snapshots). Next, their ensemble averages
(<δ>) were calculated and used to estimate the chemical-shift
perturbations upon protein-protein association (∆δ). Time/
ensemble averaged values from NMR experiments30 have been
previously deposited (BioMagRes ID: 4115 and 4114 for bound
and free Im9). We calculated corresponding values also on the
basis of the E9-Im9 X-ray crystallography structure8 as ad-
ditional validation of our six MC-MD simulations. The same
calculations were preformed for E9 CR <δ> and for both E9
and Im9 1H, 13C, 15N (not reported; available upon request to
the authors).
Correlation, Pair Distance, and Standard DeWiation Maps.
The normalized cross-correlation maps (NCCM) were calculated
as previously proposed by Hu ¨nenebrger et al.83 using the
Cartesian coordinates of all pairs of CR atoms. The maps of the
average CR-atom pair distances, <d>, and of their standard
deviations, σ, were calculated using the ensemble-averaged
distances of all pairs of CR atoms. In all cases independent E9_a,
E9_b, Im9_a, Im9_b, E9-Im9_a, and E9_Im9_b MC-MD runs
were separately employed.
Surface-Loop Conformational Clustering. Trajectory struc-
tures were clustered into batches of similar conﬁgurations using
the backbone atom-positional RMSD of Im9 residues 50-65
as the similarity criterion and the clustering algorithm previously
described84 and applied to protein surface loops.42 A cutoff of
0.2 nm was chosen after evaluation of the dependence of cluster
populations against the total number of clusters found for each
simulation (0.05-0.25 nm cutoff values range).
Hydrogen-Bond Monitoring. Hydrogen bonds were deﬁned
to have a maximum hydrogen-acceptor distance of 0.35 nm and
a minimum donor-hydrogen-acceptor angle of 120°. Only those
occurring at least 10% of the time along at least one of the two
independent MC-MD simulations were reported.
SolWent Accessibility. Solvent-accessible surface area (SASA)
values were calculated using the program NACCESS85 for
individual protein or complex structures after removing water
molecules and ions. Partial contributions to the total SASA value
were calculated42 for ﬁve classes of particles: (i) all atoms, (ii)
polar side chains (all oxygens and nitrogens in the side chains)
or (iii) nonpolar side chains (all non-oxygens and non-nitrogens
in the side chains), and (iv) side chains (all side-chain atoms)
or (v) main chain (all backbone N, C, and O atoms). For this
purpose CR atoms were classiﬁed as side-chain atoms to assign
a side-chain solvent accessibility also to Gly residues.
Salt-Bridge Monitoring. Salt bridges were monitored for all
residues throughout the seven trajectories and considered formed
when the (shortest possible) carboxylic oxygen-amino nitrogen
distance fall below 0.35 nm. This threshold was deﬁned after
analyzing the distance probability distributions for all bridging
residues. Only salt bridges occurring at least 10% of the time
along at least one of the two independent MC-MD simulations
are reported. A subgroup of these, displaying distance probability
distributions with more than one dominant peak, were deﬁned
as water-mediated salt bridges if the above-deﬁned distance fall
below 0.55 nm and simultaneously at least one (hydrogen-
bonding) water-oxygen atom was found within a sphere of 0.55
nm diameter centered at the middle point between the carboxylic
oxygen and the amino nitrogen.
Results and Discussion
MD Simulation Validation: Stability and Comparison with
Experiment. To assess the stability of the six 50 ns long MC-
MD simulations a collection of properties was monitored as a
function of time.
Figure 1a shows the backbone CR atom-positional root-mean-
square deviation (RMSD) between the trajectory structures and
the corresponding X-ray structure of the E9-Im9 complex.8
These ﬂuctuations are of small magnitude overall and remain
stable along the simulation time (standard deviations for E9-
Im9_a, 0.01; E9-Im9_b, 0.01; E9_a, 0.01; E9_b, 0.01 nm). Im9
ﬂuctuations are comparatively larger (standard deviations for
Im9_a and Im9_b: 0.03 and 0.05 nm) and demonstrate higher
structural deviations for unbound Im9 in the liquid phase. Most
of the conformational diversity observed in Im9 dynamics can
be attributed to the high ﬂexibility of its 54-64 loop (Supporting
Information, Figure S1).
In the case of unbound E9 an additional X-ray structure is
available (PDB ID: 1fsj; primary citation to be published) and
we additionally employed it to monitor corresponding RMSD
V(r) ) V0(r) + Vt(r) (2)
V
*(r) ) {V0(r) + [Vt(r) + ∆Vt(r)]} + VT(r) (3)
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The RMSD time series throughout E9_a and E9_b simulations
based on the two X-ray models are almost identical; however,
values from the unbound E9 crystal structure are shifted ∼0.025
nm to lower RMSD values (not shown).
Figure 1b displays the corresponding backbone CR atom-
positional radius of gyration (RGYR). These values ﬂuctuate
stably along the 50 ns periods, and the corresponding mean
values (E9, 1.2 and 1.2 nm; Im9, 1.4 and 1.4 nm; E9-Im9, 1.9
and 1.9 nm, respectively) show good agreement with values
from the X-ray model structure (1.2, 1.4, and 1.8 nm, respec-
tively). A somewhat more compact E9-Im9 complex structure
in the crystalline than liquid phase is expected and found due
to crystal-packing forces.
The formation of secondary structure elements was monitored
along each of our 50-ns long MC-MD runs according to the
deﬁnition by Kabsch and Sander81 and compared with the
experimental X-ray models (Supporting Information, Table S1).
All secondary structure elements are stable (not shown) and
their ensemble-averaged relative occurrences are similar between
independent MC-MD trajectories. These values are overall also
close to values from the E9 X-ray structure. On the basis of
X-ray crystal experiments E9 increases R-helix (28 to 32%) and
decreases bend (19 to 16%) formation upon Im9 binding.
However, corresponding values calculated from our simulations
in the liquid phase do not show such a behavior. This can be
explained by considering that crystal-packing forces may favor
helical vs. ﬂexible-bend elements formation.
We additionally compared Im9 conformational sampling from
our Im9_a, Im9_b, E9-Im9_a, and E9-Im9_b simulations with
available NMR experimental data in solution. The time series
of the RMSD from any of the ten reported dominant structures
in solution display values always lower than 0.31 nm (not
shown) with ﬂuctuation behavior similar to those calculated from
the X-ray model (Figure 1). The Im9 backbone CR-atom
ensemble-averaged chemical shifts, <δ>, from NMR experi-
ments and our MD simulations also show excellent agreement
along the entire Im9 residue sequence, as calculated by using
the SHIFTX program82 on all individual structures of each of
the separate six MD ensembles (Supporting Information, Figure
S2a-d). A systematic overlap is found between values
estimated from the entire 50 ns trajectories or using the last
10 ns periods only, showing that our simulations are well
converged. However, ∆δ perturbations upon E9-Im9 binding
are small relative to the chemical shift data (<0.1% of
magnitude) and within the average (over all residues) of the
standard deviation of our estimated <δ> values (∼1.1 ppm).
Similar observations could be drawn on the basis of Im9 1H,
13C, 15N chemical shifts (not reported). Overall these results
show good agreement with experiment.
E9 and Im9 Backbone Dynamics and Motional Correla-
tion Changes upon Association. Figure 2 reports the normal-
ized-cross-correlation maps (NCCM), the maps of the average
distance (<d>), and of its standard deviation (σ) for all CR atom
pairs of E9 and Im9 in their free (E9_a, E9_b, Im9_a, and
Im9_b) and bound (E9-Im9_a and E9-Im9_b) states. NCCM
maps allow to capture pairwise motional correlation along the
protein backbone; their comparison with <d> maps evidences
if lowly or highly correlated motion is experienced between
regions close or far in space on average; corresponding σ maps
show deviations from the average backbone pair distances,
pointing at pairwise ﬂexibility along the backbone. Such a novel
combination of these standard analyses provides a useful tool
to interpret overall backbone ﬂexibility and motional correlation
for biomolecular simulations.
Both E9 and Im9 proteins experience an increased overall
motional correlation upon E9-Im9 binding. This effect is
particularly evident for sequence regions E9 70-100 (3- or
R-helix secondary structure elements sampled 95% of time),
Im9 30-44 (R-helix secondary structure element sampled 98%
of time), and Im9 50-65. These regions largely encompass the
E9-Im9 binding interface residues.
The E9 NCCM from our MC-MD runs E9_a and E9_b or
E9-Im9_a and E9_Im9_b simulations are substantially similar
(Figure 2). NCCM are a sensitive measure of convergence for
MD simulation,83 thus these results conﬁrm the good conver-
gence of E9 backbone conformational sampling. Additionally,
the corresponding ensemble-averaged distance <d> maps show
that (i) these regions of highly-increased E9 motional correlation
are largely associated with relatively small CR-atom pair <d>
values (< 1.0 nm) and (ii) a very limited perturbation of <d>
values occurs upon association (Figure 2). σ maps for free and
bound E9 are also similar. These observations are in line with
the observed limited changes of backbone ﬂexibility of E9 upon
binding (Figure 3).
The Im9 NCCM maps from Im9_a and Im9_b or E9-Im9_a
and E9_Im9_b simulations are also largely similar (Figure
2). However, an interesting exception can be noticed for
residues Im9 54-64 comparing Im9_b with E9-Im9_a and
E9-Im9_b simulations. This residue sequence corresponds
to the ﬂexible Im9 54-64 surface loop, which shows different
dynamic behaviors in the two independent MD runs due to
hinged-loop opening (see next section). From the NCCM map
is clearly demonstrated that the 54-64 loop highly anti-
correlated motion (Im9_b: correlation < -0.5). A comparison
of Im9 CCM and <d> maps for the 54-64 loop in its free
and bound states shows that major changes in motional
correlations are associated with sizeable CR atom pair <d>
values (> 1.5 nm), and that a signiﬁcant increase of motional
correlation is experienced upon E9-Im9 association.
Figure 1. Time series of backbone (a) root-mean-square deviation,
RMSD, from the X-ray structure of the E9-Im9 complex and (b) radius
of gyration, RGYR, for MC-MD simulations Im9_a (black), Im9_b
(red), E9_a (green), E9_b (blue), E9-Im9_a (orange), and E9-Im9_b
(brown). All CR-atoms excluding ﬁrst ﬁve and last ﬁve residues were
used. See Table 1 for reference codes and Methods for computational
details.
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picture of Im9 being signiﬁcantly more ﬂexible than its E9
counterpart (see Figures 1, 2, and 3). The σ maps for free
and bound Im9 show that the amplitude of the deviations
from the average <d> values is signiﬁcantly reduced upon
E9-Im9 binding, particularly for the Im9 54-64 loop region.
Figure 2. Normalized cross-correlation maps, NCCM, and maps of the average distance, <d>, and its standard deviation, σ, for the CR atom pairs
of E9 and Im9 in their free (E9_a, E9_b, Im9_a, and Im9_b) and bound (E9-Im9_a and E9-Im9_b) states. For each map the upper left and lower
right triangles report values from MC-MD runs a or b, respectively. Map axes run along the residue nr. sequences. See Table 1 for reference codes
and Methods Section for computational details.
Figure 3. Backbone CR atom-positional root-mean-square ﬂuctuations, RMSF, along the amino acid sequence for the Im9 and E9 unbound proteins
(top panels) and the E9-Im9 complex (bottom panels) based on independent MC-MD runs a (black) or b (grey).
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tion partners additionally suggest that a remarkable loss of
Im9 conﬁgurational entropy occurs upon E9-Im9 binding,
while E9 dynamics is substantially affected at the E9-Im9
interface only.
Figure 3 shows the overall backbone ﬂexibility along the
amino acid sequences for comparison between the unbound (E9
and Im9) and the E9-Im9 complex ensembles. A comparison
of RMSF values between corresponding sequence regions of
the E9 or Im9 unbound proteins and the E9-Im9 complex
demonstrates a reduction of backbone ﬂexibility upon associa-
tion. Sequence regions Im9 25-45, Im9 50-70, and E9 75-95
are the most affected. These regions encompass the the E9-
Im9 interface.
In general, we note peaks of comparable intensities between
corresponding copies of MC-MD runs. Thus, we conclude that
the most ﬂexible regions of the proteins are sampling their
conﬁgurational spaces to a similar extent throughout independent
MD runs. This latter statement does not hold when comparing
Im9_a and Im9_b simulations. In fact, the region of residues
50-64 shows a pronounced mobility in both cases, but the
magnitude of the peaks in these regions is signiﬁcantly higher
in the Im9_b than Im9_a simulation (see next section).
Im9 54-64 Flexible Hinged-Loop Conformational Sam-
pling. The conformational sampling of Im9 54-64 hinged-loop,
located at the protein-protein interface in the E9-Im9 complex,
may play a fundamental role in the highly speciﬁc DNase-
immunity proteins recognition process. Wallis et al. and
Kleanthous et al. proposed that residues Tyr54 and Tyr55 are
particularly relevant in this context.8,31
Clustering trajectory snapshots into batches of highly similar
conﬁgurations is a useful tool to capture the dominant conﬁgu-
rations sampled by ﬂexible protein regions along a MD
trajectory.42 Figure 4a shows the dominant conformations
adopted, in our two independent Im9_a and Im9_b simulations,
by the Im9 loop region of residues 54-64 and allows a
comparison with the available E9-Im9 X-ray crystal structure.8
The dominant loop conﬁguration represents 89% of the Im9_a
trajectory structures. However, the central members of the most
populated ﬁrst, second, and third cluster of structures represent
41, 29, and 12% of the Im9_b ensemble, respectively. E9-Im9_a
and E9-Im9_b complex simulations display similar dominant
loop conﬁgurations representing 90 and 97% of the structures,
respectively. For simulations Im9_a, E9-Im9_a, and E9-Im9_b
there are 4, 3, and 3 clusters populated by at least 1%, totaling
98, 99, and 99% of the entire ensemble, respectively. Instead,
for simulation Im9_b we ﬁnd that 8 clusters are populated by
at least 1%, totaling 96% of the ensemble. The higher diversity
of loop-region conformations for simulation Im9_b reﬂects the
higher ﬂexibility of the surface loop in the Im9 unbound
state.
The intramolecular hydrogen-bonding and salt-bridge interac-
tions characterizing each loop dominant conﬁguration suggest that
these are stabilized by speciﬁc interactions (Supporting Information,
Table S2). The X-ray crystal structure8 displays 10 hydrogen bonds
in the 50-65 region, and includes the Asp60-Lys57 salt bridge
(Figure 4b). All of these hydrogen bonds form transiently through-
out the E9-Im9_a and E9-Im9_b trajectories. Additionally, our
simulations show that the Asp60-Lys57 salt bridge is the key
interaction determining the shape of the 54-64 loop backbone
(Figure 4c-e). During the 50 ns period, the Asp60-Lys57 salt
bridge is substituted tens of times by the Asp62-Lys57 one and
is transiently water-mediated. This emerges in the second most
populated cluster structure (Figure 4d).
Im9 Conformational Sampling from Accelerated Molec-
ular Dynamics. Enhanced sampling was achieved for the most
ﬂexible Im9 protein by using the accelerated MD (aMD)
simulation protocol by Hamelberg et al.55 (see Methods). Protein
stability along 10 ns of Im9_aMD trajectory is consistent with
what is described above for MC-MD 50-ns runs Im9_a and
Im9_b. However, aMD allows sampling a signiﬁcantly larger
conﬁgurational space, which is comparatively larger for the most
ﬂexible secondary structure elements.
Figure 5 summarizes Im9 dynamics from snapshots of our
10 ns long aMD simulation. Im9 loops 23-31 and 54-64
signiﬁcantly open with respect to the E9-Im9 X-ray structure
model8 (Figure 5a). Both loops can also transiently twist farther
Figure 4. Dominant conformations for the Im9 loop-gating region
(residues 50-65) from X-ray crystallography experiments and Im9_a
or Im9_b simulations. (a) The E9-Im9 X-ray structure (cyan tube) is
superimposed to the central members of the most populated clusters
of structures from simulations Im9_a (black tube) and Im9_b (red,
orange, and yellow tubes for ﬁrst, second, third clusters, respectively).
Cluster populations are reported using the corresponding colors.
Superimposition of all backbone CR atoms was used for all representa-
tions. The following panels summarize the key interactions within the
loop region for (b) the E9-Im9 X-ray structure and based on the central
member structures of the (c) ﬁrst, (d) second, and (e) third most
populated clusters of the Im9_b simulation. See Table 1 for reference
codes and Methods for computational details.
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the aMD simulation visits conﬁgurations close to the X-ray
model (Figure 5c). This demonstrates that the dynamic behavior
observed in our explicit solvent simulations is consistent with
the ensemble-averaged E9-Im9 crystal X-ray model. Interest-
ingly, the motion of 23-31 and 54-64 loops is not strictly
correlated, and alternatively one only of the two loops display
larger mobility (see example snapshot in Figure 5d).
A more detailed characterization of loops 23-31 and 54-64
sampling is summarized in Figure 6, comparing our MC-MD
and aMD results for key φ and ψ backbone dihedral angles.
Loop 23-31 backbone sampling is substantially identical from
Im9_a and Im9_b runs. The most highly visited regions of the
Ramachandran plot can be observed for (φ;ψ) values around
-70;50 and -60;-15 degrees for Asp26 and Ser28, respec-
tively. Asp26 conformational sampling from the Im9_aMD
simulation is signiﬁcantly extended towards the -60;120 region.
Remarkably, Ser28 extensively samples the region around
-45;130 in addition to that around -60;-15 during the aMD
run. Loop 54-64 backbone sampling differs between the Im9_a
and Im9_b runs, as discussed above. Such a different dynamic
behavior from independent MD copies can be reconciled on
the basis of our aMD simulation. The most highly visited regions
of the Ramachandran’s plot for Lys57 can be observed for (φ;ψ)
values around -120;160, -50;150, and -90;155 degrees, for
Im9_a, Im9_b, and Im9_aMD, respectively. Additionally, the
broader sampling of Im9_aMD extends to the additional region
around -55;-45. Gly59, the central residue of the 54-64 loop,
experiences the highest sampling variability between Im9_a and
Im9_b simulations, and between the dominant conﬁgurations
of this loop (see Figure 4). The most highly visited region is
around 80;0 from all three Im9 simulations. Im9_a samples as
well around -60;0, Im9_b as well around 90;-170 and
-70;-170, while aMD fully accesses all these regions. Ser61
shows a similar behavior: Im9_a samples mainly around
-60;140, Im9_b additionally around -150;-150, while
Im9_aMD covers additionally the region around -70;0.
In summary, a good correspondence is found between Im9_a
and Im9_b runs. However, these results point out the difference
between apparent (microstate) convergence and complete (mac-
rostate) sampling in MD simulations. Sufﬁcient sampling (>100
ns) in MD simulation is essential to capture slow protein
dynamics, albeit these simulations seem well converged when
trapped in speciﬁc microstates. We note that employing
independent MC-MD replicas of a same system may be an
effective way to enhance the statistics of such events as the
motion of protein surface loops. However, the aMD technique
seems a more powerful tool to explore additional regions of
the global phase space for solvated macromolecules.
Change of Surface Solvent Accessibility upon E9-Im9
Association. Table 2 reports the SASA values for the reference
unbound E9 (PDB ID: 1fsj) and complex E9-Im98 X-ray crystal
structures, as well as the ensemble-averaged values for our six
MC-MD simulations. The corresponding 50-ns long time series
along the six MD trajectories show relatively small ﬂuctuations
(maximum standard deviation from the mean values of 1.7, 1.8,
and 2.1 nm2 for E9_a, Im9_a, and E9-Im9_a, respectively; not
shown) in agreement with the observed stability. Instead, smaller
values systematically characterize the reference X-ray crystal
structures and the E9 protein in the E9-Im9 complex vs. its
unbound structure (Table 2). Interestingly, our E9_a and E9_b
unbound state simulations display SASA values closer to the
E9 unbound than to the E9-Im9 complex X-ray model, albeit
the latter was used to initialize the two independent E9_a and
E9_b simulations.
The origin of a different solvent accessibility between X-ray
crystal structures and explicit solvent MD simulations can be
detailed considering the partial contributions to the overall (all)
SASA values based separately on the polar or nonpolar, and
the side-chains or main-chain subgroups of atoms only.42
Considering either the polar or the sidechains subgroups
systematically larger average values are found for MD trajec-
tories with respect to the corresponding based on the E9-Im9
X-ray structure (see Table 2). On the other hand, considering
either the nonpolar or the main-chain subgroups similar values
are found for the same trajectories structures with respect to
the X-ray structures. The major deviations seem to be dominated
by the polar and side-chain subgroups. These trends can be
explained considering that crystal-packing forces restrict protein
motion, especially for those surface regions mainly contributing
to the solvent-accessible surface. Instead, MD simulations in
explicit solvent reproduce more closely the physical phase of
solvated proteins. Similar trends have been reported using a
different MD force ﬁeld for a different system,42 supporting
these general conclusions. A consequence of this behavior is a
substantial reduction of the number of solute-solute hydrogen
bonds observed in the liquid (MD) versus crystal (X-ray) phase
(Supporting Information, Figure S3).
The changes of surface solvent accessibility upon E9-Im9
complex formation can be quantiﬁed by comparison of all SASA
values for the E9-Im9 complex, and the corresponding sums of
unbound E9 and Im9 partners (Table 2). We observe that upon
E9-Im9 association more than 20 nm2 of E9 and Im9 protein
surfaces become inaccessible to the solvent, corresponding to
∼17% of the overall E9-Im9 complex all SASA values. A
smaller value of ∼14 nm2 would be estimated from the E9-
Im9 X-ray crystal structure, assuming that no signiﬁcant
conformational change occurs for the individual E9 and Im9
unbound partners. Unbound E9 and Im9 proteins lose a
signiﬁcant surface accessible to water due to E9-Im9 association.
Additionally, both protein surfaces experience different solvent
Figure 5. Conformational sampling of Im9 23-31 and 54-64 loops
from key snapshots of the accelerated Im9_aMD simulation (grey
cartoon) and corresponding model from E9-Im9 crystal X-ray diffraction
experiments (cyan cartoon). The two loops are shown when (a) both
open, (b) both closed, and (c) close to the X-ray model conﬁguration.
Panel (d) shows an example with 23-31 loop open while 54-64 loop
closed. See Table 1 for Im9_aMD simulation set-up and Methods for
computational details.
E9-Im9 DNase Recognition Molecular Dynamics J. Phys. Chem. B, Vol. 112, No. 51, 2008 16809accessibility depending on crystalline-like or liquid-like physico-
chemical environments.
The per-residue SASA differences upon E9_Im9 binding were
also calculated from our six MC-MD simulations (Supporting
Information, Figure S4). From this analysis we ﬁnd that a larger
number of interface residues decrease their solvent accessibility
upon E9-Im9 binding, in line with the behavior described above.
The residues affected by major changes are E9 Ser74, Tyr83,
Phe86, Lys89, and Lys97 (decreasing by about -1.1, -1.4,
-1.5, -1.6, and -1.0 nm2, respectively) and Im9 Ala23, Glu28,
Val32, Tyr52, and Tyr53 (decreasing by about -0.9, -1.7,
-1.1, -1.6, and -1.4 nm2, respectively). Previous NMR
Figure 6. Ramachandran’s plots of Im9 backbone angles φ and ψ for key residues of (a) 23-31 and (b) 54-64 loops. Color coding goes from
red (low population) to blue (high population). Convergence between independent MC-MD runs can be addressed by comparison between Im9_a
and Im9_b simulations (left and middle columns). Corresponding results, are shown on the basis of the accelerated Im9_aMD simulation (right
column), after quasi-canonical re-weighting. See Table 1 for reference codes and Methods for computational details.
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critical residues experiencing the largest peptide 15N amide ∆δ
perturbations upon E9-Im9 complexation.58 The comparison of
per-residue SASA change with NMR experimental data ad-
ditionally supports the observation that a determinant of
complex-induced chemical shifts is the change of solvent
exposure experienced by speciﬁc N-H groups.86
Salt-Bridge Formation and Pre-Organization: MD versus
X-ray Crystallography. Analysis of the salt bridges was carried
out along the six MC-MD trajectories (i) to investigate the
correspondence between simulations and X-ray crystallography
data, (ii) to evaluate the changes of salt-bridge formation upon
E9-Im9 complexation, and (iii) to elucidate to what extent
residues involved in salt bridges are pre-organized in the
unbound states.
Figure 7 summarizes the results for the unbound E9 and Im9
states and the E9-Im9 complex using the statistics over pairs
of independent MD runs. All possible salt-bridging residue pairs
were taken into account. Only those with a salt-bridge occur-
rence of at least 10% of the individual simulation time are
reported (see Methods Section).
A good correspondence is found comparing the E9-Im9_a
and E9-Im9_b simulations with the E9-Im9 complex X-ray
crystal structure.8 Out of seven salt-bridges in the X-ray model
ﬁve are also highly formed during our simulations. Im9
Glu30-E9 Arg54 and Im9 Glu41-E9 Lys97 involve hot-spot
residues. E9 Asp64-E9 Arg37, E9 Glu59-E9 Lys55, and E9
Glu 100-E9 Arg96 (the latter water-mediated) are formed on
the E9 surface. Only E9 Asp40-E9 Arg43 and Im9 Glu45-Im9
Arg75, found in the E9-Im9 complex X-ray crystal structure,8
occur less than 2% of the time during our MD simulations.
Considering these latter two are on the protein surface their
higher formation in the E9-Im9 crystal may be explained by
crystal-packing effects. No salt-bridge occurring between Im9
residues has occurrence of at least 10% of the time throughout
the E9-Im9_a and E9-Im9_b simulations.
The same analysis shows that a signiﬁcant number of salt
bridges revealed by MD simulations in explicit water would
not emerge from an analysis limited to the X-ray crystal model
(E9-Im9 complex: 17 out of 22). Remarkably, Im9 Glu31-E9
Arg96 and Im9 Glu41-E9 Lys89 revealed by E9-Im9_a and
E9-Im9_b simulations, not present in the X-ray E9-Im9 complex
structure, involve interface interactions. The second of these
E9-Im9 interface salt bridges can explain the substantial free-
energy change upon binding (∼9k Jm o l -1) calculated based
on kinetic and ﬂuorescence experiments.31 Sinha et al. recently
reported intra- and intermolecular salt bridges, not detected by
X-ray crystallography, using short MD simulations of antibody-
antigen association.87 We suggest that MD simulations may in
general improve the description of PPIs based on X-ray models.
The comparison of salt-bridge formation between unbound
(Figure 7a) and bound (Figure 7b) states provides information
TABLE 2: Comparison of Ensemble-Averaged
Solvent-Accessible Surface Areasa from X-Ray Crystal
Structures and MC-MD Simulation in Water
< SASA > [nm2]
ref code all polar non-polar
side
chains
main
chain
X-ray structure
E9b 80 33 (44) 47 (56) 70 (87) 10 (13)
E9c 74 32 (43) 42 (57) 66 (89) 8 (11)
Im9c 49 22 (45) 27 (55) 43 (88) 6 (12)
E9-Im9c 109 48 (42) 61 (58) 96 (86) 13 (14)
explicit solvent
MC-MD simulation
E9_a 82 37 (45) 45 (55) 71 (86) 11 (14)
E9_b 80 36 (45) 44 (55) 70 (87) 10 (13)
Im9_a 59 28 (47) 31 (53) 50 (85) 9 (15)
Im9_b 58 28 (48) 30 (52) 49 (84) 9 (16)
E9-Im9_a 118 55 (47) 63 (53) 101 (86) 17 (14)
E9-Im9_b 120 56 (47) 64 (53) 103 (86) 17 (14)
a The values calculated using all, polar or nonpolar, and
side-chains or main-chain atoms subgroups are reported separately.
Relative percent values are given in parentheses (with respect to all
values). See Methods for computational details subgroups deﬁnition.
b E9 unbound from PDB ID: 1fsj; same sequence as in ref 8 and
MD model; energy minimized. c E9-Im9 X-ray structure (ref 8);
energy minimized.
Figure 7. Salt-bridge formation along (a) the unbound states E9_a,
E9_b, Im9_a, and Im9_b simulations and (b) the complex E9-Im9_a
and E9-Im9_b simulations. Orange and black denote salt bridges
between residues of E9 or Im9, respectively. Red and brown denote
water-mediated salt bridges between residues of E9 or Im9, respectively.
Blue denotes salt bridges between Im9-E9 complex partners. Only
salt bridges occurring >10% in at least one of the two MC-MD runs
are reported. X labels salt bridges also occuring in the X-ray model.
See Table 1 for reference codes and Methods for computational details.
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intercomplex salt bridges are overall highly formed: Im9
Glu30-E9 Arg54, Im9 Glu31-E9 Arg96, Im9 Glu41-E9 Lys
89, and Im9 Glu41-E9 Lys97. In the ﬁrst case, we ﬁnd that
E9 Arg 54 is involved in a stable salt-bridge with E9 Asp51 in
the unbound state. In the second case, E9 Arg96 forms a stable
salt bridge with E9 Glu100 in the unbound state. The third and
fourth cases involve a multiple salt-bridge interactions between
Im9 Glu41 and both E9 Lys89 and E9 Lys97. In all four cases,
it seems evident that no static preorganization occurs; instead,
dynamic sampling of favorable binding conﬁgurations may be
transiently experienced. This is a crucial point to the more
fundamental understanding of biomolecular association.51,52
Im9 Asp51-Lys57 Salt-Bridge Dynamics and Its Role in
E9-Im9 Recognition As a Surface-Loop Switch. Wallis et al.
reported a less favorable (∼25 kJ mol-1) E9-Im9 binding free
energy due to Im9 Asp51Ala mutation, calculated based on a
stopped-ﬂow ﬂuorescence experiment.31 Asp51Ala mutation is
the one affecting E9-Im9 binding the most out of 34 reported.
Kleanthous et al.8 proposed that mutations Tyr54Ala and
Tyr55Ala, among others, are essential for binding afﬁnity and
speciﬁcity. Instead, it has not yet been clariﬁed the outstanding
effect of Asp51Ala mutation in E9-Im9 recognition. We used
our MC-MD Im9_a, Im9_b, E9-Im9_a, E9-Im9_b runs and
accelerated Im9_aMD simulations to elucidate this point.
The preferred conformations of loop 54-64 are signiﬁcantly
dominated by the interactions formed by Lys57 within the loop
region itself. From our MD simulations we observe loop
conﬁgurations similar to the X-ray model (Figure 4). Addition-
ally, loop dynamics events occurring on longer time scales can
be observed on the basis of the Im9_aMD simulation (Figure
5). Our simulations reveal a larger number of key salt-bridge
interactions than the X-ray model (Figure 7) also based on
Im9_aMD (not shown). Lys57 forms transient hydrogen bonds
to Asp60 and Asp62 throughout the Im9_aMD trajectory (Figure
8a). This corresponds to what observed from regular Im9_a and
Im9_b simulations (Figure 4). Interestingly, Im9 displays also
two alternative dominant conﬁgurations during the 10-ns aMD
period, both characterized by a stable Asp51-Lys57 salt bridge
(Figures 7 and 8b,c). In the ﬁrst case, the 54-64 loop is open,
in the second further closed than the X-ray model. The
re-weighted normalized probability distribution of the Asp51:
CG-Lys57:NZ distance conﬁrms that the formation of this salt
bridge, observed using aMD only, is also energetically stabilized
(see largest peak at ∼0.35 nm, Figure 8d). Asp51Ala mutation
prevents the Asp51-Lys57 salt-bridge anchoring of the 54-64
loop in its ideal conﬁguration for E9 binding, with a consequent
decrease of E9-Im9 binding free energy. We summarize this as
a molecular switch that shifts Lys57 intraloop interactions to
interactions with the more rigid helix III through a Asp51-Lys57
salt bridge.
E9-Im9 Interface Residues: Conformational Spaces and
Hydrogen Bonding. We monitored the conformational sam-
pling of side-chain  1 and  2 dihedral angles and solute-solute
hydrogen bonding of E9-Im9 interface residues using simula-
tions E9_a, E9_b, Im9_a, and Im9_b of the free states and
simulations E9-Im9_a and E9-Im9_b of the bound state.
Im9 residues Ile22, Cys23, Ser28, Glu30, Leu33, Ser50,
Asp51, Ile53, Tyr54, Tyr55, and Asp62 show signiﬁcant
conformational changes upon binding. The largest shifts in
dihedral sampling were observed for Glu30, Asp51, and Tyr55.
Of these 11 residues, based on NMR studies,30,58 5 are in the
group of those displaying the largest ∆δ perturbations upon
binding (Ser28, Ser50, Ile53, Tyr54, and Tyr55), 2 in the
intermediate group (Cys23 and Leu33), and 2 experience small
perturbation (Ile22 and Asp51). No signiﬁcant perturbation could
be revealed for Asp62, while no chemical shift was measured
for Glu30.
E9 residues Arg54, Asn72, Ser77, Tyr83, Ser84, Lys89, and
Gln92 display similar large conformational changes upon
binding (not shown). Overall, good correspondence is observed
between independent MC-MD runs and a reduction of accessed
dihedral space upon binding is expected and found. Remarkable
differences between two MC-MD replicas are only evident for
distributions of Im9 Asp51 and Tyr55 and can be explained
considering the different 54-64 loop sampling for simulations
Im9_a and Im9_b (see Figures 2, 3, and 4).
We also investigated the dynamics of the E9-Im9 interface
analyzing solute-solute hydrogen bonds. We report separately
these results considering all possible E9 and Im9 intramolecular
hydrogen bonds highly formed (>10% time occurrences) in both
free and bound states, and E9-Im9 intra- and intermolecular
hydrogen bonds formed upon association (Supporting Informa-
tion, Figure S5). Out of 17 newly formed upon E9-Im9
recognition, 9 involve intermolecular interactions between the
E9 and Im9 partners (Supporting Information, Figure S5c). A
number of new hydrogen bonds are formed upon E9-Im9
binding (Supporting Information, Figure S5c). Interestingly, this
E9-Im9 hydrogen bond network favors the occurrence of those
intramolecular hydrogen bonds also present in E9 and Im9
unbound states (compare Supporting Information, Figure S5a,b
versus Figure S5c). This is shown for E9 and Im9 in 16 and 18
cases out of 22 and 21, respectively (Supporting Information,
Figure S5a,b). Im9 intramolecular Ile53:NH-Ser50:O and
Tyr54:NH-Ser50:O and E9-Im9 intermolecular hydrogen bonds
Tyr55:OH-Thr87:N and Tyr55:OH-Phe86:O play an important
role in E9-Im9 binding thermodynamics.29
These results suggest that in general no preorganization of
the residues involved in E9-Im9 recognition is strictly required.
Instead, E9-Im9 binding involves shifts of conformational
Figure 8. Conformational sampling of the Lys57-Asp51 salt bridge
from key snapshots of the accelerated Im9_aMD simulation. Panel (a)
shows Lys57 interacting with loop 54-64 residues when the salt bridge
is not formed. Alternatively, the Lys57-Asp51 salt bridges can be
formed when the 54-64 loop is (b) open or (c) closed. Panel (d)
displays the corresponding quasi-canonical re-weighted normalized
distribution of the salt-bridge distance.
16812 J. Phys. Chem. B, Vol. 112, No. 51, 2008 Baron et al.distributions, reorganization of E9 and Im9 intramolecular
hydrogen-bond patterns, and formation of new intermolecular
E9-Im9 interactions. However, a few residues at the interface
(e.g., E9 Lys97; Im9 Glu41) seems to experience very limited
rearrangements upon binding.
Conclusions
Changes of E9 and Im9 dynamics in water upon E9-Im9
colicin DNase-Immunity protein recognition were investigated
using a combination of multiple-copy (MC) MD and accelerated
MD (aMD) simulation approaches. Overall, our simulations
show good general stability and are consistent with the available
experimental data. After validation with X-ray crystallography
and solution NMR experiments, these simulations provide a
dynamic picture at the atomic level of E9-Im9 recognition in
water and allow a number of conclusions.
First, Im9 is signiﬁcantly more ﬂexible than its E9 counter-
part, both in its free and bound states. However, due to a
decrease in ﬂexibility, the backbone motional correlation
increases for both E9 and Im9 proteins upon binding. This effect
is larger for Im9, and involves also highly correlated motions
for Im9 backbone atom pairs at high distances (> 1.5 nm).
Sequence regions Im9 25-45, Im9 50-70, and E9 75-95,
encompassing the critical residues at the E9-Im9 interface,
display the largest reduction of ﬂexibility upon association.
Second, ﬂexible protein surface loops are a determinant of E9-
Im9 recognition speciﬁcity in the liquid phase. The Im9 54-64
hinged loop shows high conformational diversity. Through the use
of conformational-clustering, salt-bridge, and hydrogen-bonding
analyses we propose that Lys57-Asp60 salt bridge is the key
intraloop interaction determining the shape of the 54-64 loop,
particularly that associated with free Im9 for subsequent complex
formation. The dominant loop conﬁgurations are modulated by
speciﬁc hydrogen-bond patterns, which play an essential role in
the DNase-immunity protein recognition process. We observe that
Im9 loops 23-31 and 54-64 in solution open signiﬁcantly with
respect to the X-ray crystal model.
Third, we observe that upon E9-Im9 association a large part of
E9 and Im9 protein surfaces (∼20 nm2) become inaccessible to
the solvent, corresponding to ∼17% of the overall solvent acces-
sible surface area of the E9-Im9 complex. A signiﬁcantly smaller
value (∼14 nm2) would be estimated based on the E9-Im9 and E9
X-ray crystal structures currently available, assuming a rigid-body
behavior. This observation points to the remarkable plasticity of
the Im9 protein and to its key role in E9-Im9 binding.
Fourth, a signiﬁcantly higher number of salt bridges is
revealed by MD simulations in explicit water than from the
X-ray crystal model (17 out of 22 for the E9-Im9 complex).
Importantly, among these salt bridges, Im9 Glu31 - E9 Arg96
and Im9 Glu41-E9 Lys89 involve important interface interac-
tions. Based on our simulations, we can thus explain the binding
free-energy contribution of Glu41-Lys89 salt bridge (∼9k J
mol-1) calculated based on previously reported kinetic and
ﬂuorescence experiments.31
Fifth, a comparison of conformational sampling of Im9-E9
salt bridges Glu30-Arg54, Glu31-Arg96, Glu41-Lys89, and
Glu41-Lys97 with the corresponding unbound Im9 and E9
sampling of these residues shows that no static pre-organization
occurs. Instead, dynamic sampling of tens of favorable binding
conﬁgurations likely occurs during the existence of the initial
encounter complex.
Sixth, the atomic-level dynamic information provided by
simulations in the liquid phase can be used to follow the
conformational sampling of speciﬁc residues and their transient
interactions. For example, in relation to Im9 Asp51Ala mu-
tagenesis and its effect on E9-Im9 binding, this allowed us to
reconcile Im9 dynamics with liquid-phase kinetic experiments
and corresponding calculated thermodynamic data.31 Impor-
tantly, the same observations would not emerge from an analysis
limited to the ensamble-averaged X-ray model.8 These results
are a ﬁrst important step to explain the link between the free-
energy changes upon binding and Im9 dynamics. We ﬁnd that
the large thermodynamic impact of Asp51Ala mutation (∼25
kJ mol-1) is due to the resulting loss of anchoring of the 54-64
loop in its ideal closed position for E9 binding. Thus, we suggest
that Lys57 acts as an essential molecular switch to shift this
Im9 surface loop towards an ideal conﬁguration for E9 recogni-
tion. This is achieved at the molecular level by switching Asp
62-Lys57 and Asp60-Lys57 intraloop hydrogen bonds to a
Asp51-Lys57 salt bridge. This likely contributes to the high
afﬁnity and speciﬁcity of E9-Im9 binding.
Seventh, a comparison of dihedral sampling and hydrogen
bonding for interface residues of the E9, Im9, and E9-Im9
ensembles shows that no preorganization of residues in E9-Im9
recognition is strictly required. Instead, E9-Im9 binding involves
shifts of conformational distributions, reorganization of intramo-
lecular hydrogen bond patterns, and formation of new inter-
molecular E9-Im9 interactions.
Overall, we demonstrate the importance of an atomic-level and
dynamic view of E9-Im9 recognition in solution. Three major
general conclusions are supported by our study. First, protein
surfaces are signiﬁcantly perturbed depending on different crystal-
line-like or liquid-like physico-chemical environments. Second,
sufﬁcient sampling (> 100 ns) in MD simulation is essential to
capture slow protein dynamics, albeit simulations of such a
timescale may seem to be well converged when trapped in speciﬁc
microstates. Therefore, assessing the convergence of protein
simulations should distinguish between local phase-space property-
convergence (apparent convergence) from global sampling of the
potential energy surface (actual convergence). Indeed, employing
independent MC-MD replicas of a same system may be an effective
way to enhance the statistics of rare events, as the motion of protein
surface loops. However, after quasi-canonical re-weighting of the
conﬁgurational ensembles, the aMD technique seems a more
powerful tool to explore additional regions of the global phase space
for solvated macromolecules. We ﬁnd that aMD (10 ns) outper-
forms two independent copies of MC-MD (50 ns each) in sampling
the biologically-relevant low-frequency motions of the ﬂexible Im9
inhibitor protein. Third, MD simulations provide atomic-level and
time-dependent information of biomolecular systems otherwise
inaccessible to experiments that can signiﬁcantly enrich our current
view of biomolecular association and assist the essential develop-
ment of modeling and bioinformatics technology.
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